Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The osmotic gradient at the ocular surface refers to the difference in osmolarity between the tear film and the underlying ocular surface epithelial cells. This gradient regulates water movement, maintains cell integrity, and supports normal vision. Disruption, especially increased tear film osmolarity (hyperosmolarity), is a key factor in dry eye disease pathogenesis.
Hypo-osmotic eye drops dilute hyperosmolar tears to reduce cellular stress and inflammation. Anti-inflammatory therapies target cytokine and MMP cascades activated by hyperosmotic stress.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic Gradient at the Ocular Surface (None).